I think the market and sector is in a holding pattern until we see what happens with Russia and the Ukraine. US intelligence indicates an attack this week (with some details indicating a false flag on Tuesday and attack on Wednesday). If we can get through this week without an attack then perhaps some of […]
2 Biotech Stocks In The Breakout Territory
Biotech traders have to adapt to any changes in the stock market, trying to adjust their trades and the game plan along with the markets condition. It is easier to take swing trades, long or short during a bull or bear market, but lately the choppiness and indecision hurt both longs and the shorts […]
Upcoming Phase 3 trials
With a fresh start to 2014 and the biotech market still very strong, we wanted to examine some upcoming Phase 3 results that will be in focus in the first quarter. Expectations for some of these trials varies widely. We have a blend of small biotech to big pharma. Company: Merck (MRK) and Amgen (AMGN) […]
Week’s Option Activity (12/27 ~ 1/9)
The following stocks had notable activity in their options during the past week(s): $GERN (12/27): 663 JUN 5.0 strike Calls (stock at $5.10) were purchased for 1.40 or total cost of $92,820. Buyer makes money if stock trades above $6.40 by June expiration. $CHTP (12/31): 5,500 JAN 4.0 strike Puts (stock at $4.40) were purchased […]
